The oncogene Yes-associated protein (YAP) and its paralogue Transcriptional Co-Activator With PDZ-binding Motif (TAZ or WWTR1) have been considered as attractive pharmacological targets, as they are highly activated in many forms of cancers and contribute to tumor growth and invasion (39). The gene discussed is YAP1; the disease is cancer.